Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Funding Announcements: April 2013

The following new grants were awarded to JCCC members in April 2013:

.Principal Investigator: Chmielowski, Bartosz

Sponsor Name: Bristol-Myers Squibb Company

Award Title: Randomized, Open-Label Phase III Trial of Bms-936558 versus Investigator's Choice in advanced (Unresectable or Metastatic) Melanoma Patients Progressing Post Anti-CTLA-4 therapy

Principal Investigator: De Vos, Sven

Sponsor Name: Merck and Company, Incorporated

Award Title: Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor Or Hematologic Malignancy

Principal Investigator: Finn, Richard

Sponsor Name: Translational Research in Oncology (TRIO-US)

Award Title: Randomized, Multicenter, Double-Blind Phase 3 Study of PD-0332991 Plus Letrozole Versus Placebo Plus Letrozole for the Treatment of Postmenopausal Women with ER(+), HER2(-) Breast Cancer Who Have Not Received any Prior Systemic Anti-Cancer Treatment for Advanced Disease

Principal Investigator: Finn, Richard

Sponsor Name: Agensys, Inc.

Award Title: Preclinical Research Program to Evaluate Potential Translational Science Agensys ADC Payloads and Conjugates

Principal Investigator: Harrison, Gail

Sponsor Name: U.S. Dept. of Agriculture/Economic Research Service

Award Title: Food Insecurity, Health and Disability in the National Health Interview Survey

Principal Investigator: Iruela-Arispe, Luisa

Sponsor Name: NIH/National Heart, Lung and Blood Institute

Award Title: Induction of Vascular Morphogenesis

Principal Investigator: Jung, Michael

Sponsor Name: Brentwood Biomedical Research Institute

Award Title: Targeting Deptor in Multiple Myeloma

Principal Investigator: Lai, Albert

Sponsor Name: Accelerate Brain Cancer Cure, Inc.

Award Title: Pre-Clinical Studies Investigating the Use of Isotretinoin for the Treatment of IDH1 Mutant Glioma Patients

Principal Investigator: Martinez, Otoniel

Sponsor Name: Multiple Myeloma Research Foundation

Award Title: Treating Multiple Myeloma Using Anti-CD138 Genetically Fused To Type 1 IFN

Principal Investigator: Pantuck, Allan

Sponsor Name: Argos therapeutics, Inc.

Award Title: International Phase 3 Randomized Trial of autologous Dendritic Cell Immunotherapy (AGS-003)Plus Standard Treatment of advanced Renal Cell Carcinoma

Principal Investigator: Reiter, Robert

Sponsor Name: Agensys, Inc.

Award Title: Evaluation of the Efficacy and Effect of AGS-PSCA on Tumor Growth and Progression in a Genetically Engineered Mouse Model of Prostate Cance

Principal Investigator: Ribas, Antoni

Sponsor Name: National Marrow Donor Program

Award Title: Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood

Principal Investigator: Torres, Jorge

Sponsor Name: Research Corporation

Award Title: Novel Chemical Probes for Dissecting the Mechanisms of Cell Division

Principal Investigator: Van Dam, Robert 

Sponsor Name: Sofie Biosciences, Inc.

Award Title: Commercialization of a Microscale, Point-of-Use Radiosynthesis Device for the Development and Production of Pet Probes

Principal Investigator: Wang, Cun Yu

Sponsor Name: NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases

Award Title: Molecular Control of MSC Differentiation and Bone formation by KDM4b


Last updated: 12/17/2014 5:29:01 PM